Hagag Real Estate: Record Sales Are Here, but the Real Test Is Turning Them Into Cash
Hagag ended 2025 with record sales, a major move into Sde Dov, and a new yielding layer through Rani Zim, but the filing shows that even after the diversification, the story remains cash-heavy and dependent on surplus releases, permits, and financing. 2026 reads like a balance-sheet and cash-conversion test year, not a comfort year.
Getting To Know The Company
From the outside, Hagag Real Estate can look like a broad property platform, purchase groups, entrepreneurial development, hotels, commercial assets, yielding assets, and now Rani Zim. In practice, even at the end of 2025, the economics still rest on one main engine: high-end development in Tel Aviv that has to carry marketing, financing, and a lot of time at once. This is not a classic NOI company, and it is not a relaxed holding company either. It is a development platform that creates value when projects move forward, but consumes a great deal of balance-sheet capacity until that value becomes cash.
What is working right now is sales velocity. In 2025 the company signed binding sale agreements for 175 housing units, 7 land units, and about 1,700 square meters of commercial space, totaling about NIS 1.544 billion including VAT. Around the filing, together with Hagag-Zim Real Estate, sales during and after the reporting period already reached about NIS 2.3 billion including VAT, led by a strong campaign in the FIRST project in Sde Dov. On top of that, the company added a new yielding layer through Rani Zim, giving it a second leg beyond residential development.
What is still missing for a cleaner read is cash conversion. Reported revenue fell to NIS 388.6 million, while operating cash flow turned negative by NIS 866.5 million, mainly because of the Sde Dov land acquisition. In other words, sales are running ahead of revenue recognition, and revenue recognition is running ahead of the cash that remains after land, financing, and real cash uses. That is why 2026 is not just another "growth year." It is a bridge year between record sales and a test of monetization, surplus release, and refinancing.
Another easy mistake is to think diversification has already solved the concentration problem. It has not. Rani Zim clearly adds a second layer of value, but value created inside an associate is not the same as value already accessible to common shareholders in the listed parent. Shadal also looks like attractive optionality on paper, but until there is either a binding sale or a more stable financing path, it remains a bottleneck as well.
At the center of all this stands a company with a market cap of about NIS 1.6 billion, 61 employees, and four active bond series, a company the market reads first through its balance sheet and project stack, and only then through the income statement. That is the right reading here too.
| Layer | What is working today | What still blocks a clean read |
|---|---|---|
| Residential development | High sales velocity, especially in FIRST Sde Dov, Sommeil, and Bavli | Revenue recognition and cash timing are still lagging sales |
| Business diversification | Rani Zim adds a yielding commercial-center leg | The value sits in an associate, so not all of it is directly accessible to Hagag shareholders |
| Asset optionality | Shadal advanced on the planning side and the company is also examining a partial conversion of hotel rights into residential | The sale was not signed, exclusivity expired, and the credit was only extended to June 30, 2026 |
That chart puts the story in order immediately. There is no top-line surge in 2025. There is some improvement in reported profitability, but above all there is a widening gap between what was sold, what has already passed through the statements, and what has actually become cash.
Events And Triggers
Sde Dov Moved From Strategic Promise To Balance-Sheet Commitment
The first trigger: Sde Dov. In March 2025 the company won a 4,924 square meter plot with rights for up to 350 housing units, 1,491 square meters of commercial space, and 2,380 square meters of office space. By the filing date, total consideration, including development charges, had been fully paid, about NIS 803 million, plus VAT and purchase tax. This was the move that changed the 2025 balance sheet more than anything else.
The positive side is obvious. Already in 2025 the project sold 132 housing units and 1,700 square meters of commercial space, with expected contracted revenue of about NIS 958.6 million and a 40.1% marketing rate by year-end. After the reporting period, another 23 contracts were signed at an average price of NIS 64,035 per square meter. On the business-plan level, the company shows expected gross profit of NIS 767.8 million and a 32.2% gross margin.
The other side matters just as much. At the end of 2025 the project's completion rate was still 0%, no full construction accompaniment agreement had yet been signed, and no main contractor had yet been secured. The project still depends on years of spending before delivery. In addition, there are two external frictions that do not depend only on the company: a planning condition under which residential permits above 10,000 units in the wider plan area require full execution of Park HaMaslul and Park HaHof, and the wait for drilling and environmental guidance around the PFAS issue in the Sde Dov area. Hagag's own lot had not been marked as suspect by the report date, but the company states it is still waiting for drilling on its land and for guidance from the Ministry of Environmental Protection.
The key point in that chart is not only how large Sde Dov already is. It is that the company is now relying on this project as a flagship commercial story well before it has become a flagship cash-flow story.
Rani Zim Adds Diversification, but Not a Shortcut to Shareholder Cash
The second trigger: the completion of joint control in Rani Zim Shopping Centers. Hagag now holds about 30.29% of the company, which owns 15 active shopping centers spanning about 140,000 square meters, and also holds 50% in a data-center project on about 12,500 square meters with expected capacity of about 16 MW IT.
This is a meaningful addition. It broadens Hagag beyond residential development into a more yielding and diversified layer, and it also created a NIS 38.4 million bargain-purchase gain in 2025, on top of the NIS 50.4 million already recognized in 2024, while contributing NIS 10.1 million of equity income.
But this is exactly where the reader should avoid overstatement. This is not a free-cash layer yet. Rani Zim sits inside Hagag as an associate. So a large part of the new value is still created first at the level of fair value, equity accounting, and optionality, and only later, if and when it happens, at the level of cash truly accessible to Hagag common shareholders. Put differently, Rani Zim improves the mix, but it does not erase Hagag's need to finance, deliver, and release surpluses from its own development projects.
Shadal Remains Both Upside And Bottleneck
The third trigger: Shadal. This is where it is very easy to confuse value created with value already accessible. On the one hand, Had Master, in which Hagag indirectly holds 50%, completed the conditions required for the building permit and is waiting for the permit-fee bill. The project includes rights for about 120 housing units, about 320 hotel rooms, commercial space, and parking, and the company is also examining the option of converting part of the hotel rights into residential rights.
On the other hand, the immediate reports around the filing sharpen that this project has still not become cash. In February 2026 the exclusivity period for the sale of rights was extended to March 2, 2026. On March 4, 2026 that exclusivity expired without a binding agreement, even though negotiations continued. And on March 30, 2026 Had Master's bank credit facility, totaling NIS 405 million, was extended from April 1, 2026 to June 30, 2026.
That is the core point. Shadal can become a strong value lever. But as long as there is no binding sale and the credit facility keeps getting pushed only a few months forward, the project functions not only as upside optionality but also as a financing bottleneck.
The Debt Market Is Still Open, but It Does Not Solve the Story
The fourth trigger: market access remains open. In January 2025 the company issued Series 15, and in March 2026 it completed a private placement of NIS 68 million par value from Series 14 for NIS 69.156 million gross, about NIS 68.9 million net, for general operations.
That is an important sign, because it shows the market has not shut the door. But it is still not the same thing as risk removal. Series 14 carries 6.5% interest, and its first principal payment, 30% of the series, is due already on July 1, 2026. So financing is available, but it is short enough to keep the company working under pressure.
Efficiency, Profitability, And Competition
Reported Profitability Improved, but It Does Not Tell the Whole Story by Itself
The good news is that gross profit rose in 2025 to NIS 159.3 million, from NIS 149.0 million in 2024, despite revenue declining to NIS 388.6 million. Gross margin improved from about 35.7% to about 41.0%. That is real improvement, driven by gross profit recognition from projects under execution, management fees in Einstein 35 and Salame, and entrepreneurial profit from land-rights sales in Einstein 33A.
But anyone stopping there misses the real composition of earnings. In 2025, ordinary profit also relied on NIS 25.7 million of fair-value gains on investment property, NIS 38.4 million from bargain purchase, and NIS 10.1 million of equity income. That does not mean the profit is "not real." It means 2025 earnings still reflect accounting and investment-structure layers, not only apartment deliveries and clean development margin.
That chart matters because it shows Hagag's 2025 problem is not a lack of profit. It is that profit still carries a very heavy financing burden. Net finance expense already reached NIS 70.3 million, up from NIS 55.8 million in 2024.
Sales Quality Improved Versus 2024, but Concessions Are Still Material
This is one of the most important findings in the filing. In 2024 almost all sales operated with index-relief concessions: NIS 698 million, or 91% of total sales. In addition, NIS 250 million of sales were done through developer loans. In 2025 the picture improved, but did not become clean: index relief declined to NIS 646 million, or 42% of sales, and developer loans almost disappeared to just NIS 6 million. At the same time, NIS 507 million of sales still used 20/80 terms, and NIS 1.031 billion used linear installments.
In plain language, the company stepped back from the most aggressive 2024 model, but it is still selling a meaningful share of inventory under terms that make life easier for the buyer and somewhat heavier for the company, whether through non-indexation or more comfortable payment schedules.
The chart shows the right change. 2025 no longer looks like 2024, but it also does not look like a fully normalized market. Anyone trying to tell a story of "record clean sales" is smoothing over this point.
The friction works in two ways. First, the Bank of Israel already signaled in March 2025 that financing promotions raise risk for buyers, developers, and the banking system, and its temporary directive pushed the company to focus mainly on developer loans and index relief. Second, the company itself says that in deals with easier payment terms or index relief it does not perform independent underwriting of the buyers. In developer-loan deals it relies on the bank's underwriting, but for the other concessions it is simply using a more flexible commercial structure.
That is not necessarily an immediate problem, but it is definitely a growth-quality question. Especially when we remember that 4 transactions totaling about NIS 26 million including VAT were canceled in 2025, and another 18 applications in FIRST were canceled because of planning changes. That is not a crisis, but it is also not a number to ignore.
What Really Drives Competition Here
Hagag has a clear advantage in Tel Aviv and nearby demand zones: product design, project planning, and campaign timing. That is visible in Sde Dov, Sommeil, and Bavli. But this advantage only translates into shareholder value if the company can hold three things together at the same time: sales velocity, financing discipline, and permit execution.
If one of them gets stuck, the planning edge is not enough on its own. That is especially true in a market where interest rates are still high, industry inventory is large, and regulation around payment terms has narrowed developers' room to maneuver.
Cash Flow, Debt, And Capital Structure
In this analysis I am using an all-in cash flexibility lens. That is the right frame for Hagag in 2025, because the key question is not how much normalized earnings power the business might have in theory, but how much real flexibility remains after land, financing, taxes, and other actual cash uses.
Cash Flow: 2025 Was a Consumption Year
Operating cash flow was negative by NIS 866.5 million. This was not just "weak cash flow." It was a full consumption year. According to the company, the gap mainly came from land inventory purchased in Sde Dov, development charges, and purchase taxes totaling about NIS 870 million, plus about NIS 124 million of VAT on the transaction, which was later refunded during the period.
That chart says almost everything. Without open banks and an open debt market, 2025 would have looked very different. The company paid NIS 234.8 million of interest and NIS 51.2 million of net taxes, and still ended the year with NIS 120.3 million of cash and cash equivalents, down from NIS 141.6 million at the end of 2024. In other words, the system kept working, but it worked under real dependence on external financing.
Covenants Are Not Tight. Maturities Still Matter
The good news is that the company is not sitting on the verge of covenant breach. Adjusted equity, including minorities, stood at about 31% of the balance sheet at the end of 2025, versus a 25% floor in the bond covenants. Adjusted equity, excluding minorities, stood at about NIS 1.423 billion, versus minimum thresholds of NIS 500 million, NIS 625 million, and NIS 675 million across the bond series. Restricted solo debt was only 0.9%.
So the story is not "a covenant breaking tomorrow morning." The story is different: the company still needs to refinance, roll debt, and release surpluses at a pace that justifies a much larger balance sheet. That difference matters. Acute covenant pressure is not the issue here. Financing pressure and timing are.
The balance sheet shows this clearly. Non-current liabilities jumped by NIS 1.045 billion, mainly because of NIS 643 million of land financing in Sde Dov, additional credit in Marina, and the reclassification of Lodwipol credit from short term to long term. At the same time, current liabilities fell only modestly, because while short-term project debt declined in some places, solo facilities and Sommeil credit increased. Put differently, debt did not only grow. It also became more complex.
Capital Allocation Still Reads as Aggressive
Equity attributable to shareholders rose to NIS 1.359 billion, from NIS 1.248 billion in 2024. That is positive. But it is hard to read 2025 as a "comfortable balance-sheet year," because alongside the heavy financing burden the company also repurchased shares for about NIS 8 million at an average price of NIS 22.8 per share, and after the balance sheet date the board also approved a NIS 33 million cash dividend.
That is not necessarily wrong. Management may simply be signaling confidence and implementing its payout policy. But from a conservative reading, it sharpens the point that Hagag is choosing to stay aggressive in capital allocation even in a year when operating cash flow was deeply negative.
Outlook
Four Findings To Keep in Mind
First: Hagag should not be measured in 2026 only through sales velocity, but through the conversion rate from sales into free cash.
Second: sales quality improved versus 2024, but not to the point where the concession question disappears. Index relief on 42% of 2025 contracts is better than 91%, but it is still not a fully normal market.
Third: Rani Zim improves the business mix, but it does not by itself solve the question of cash access at the parent-company level.
Fourth: Shadal is no longer just upside optionality. It is part of the financing bridge of the story, so every delay there now feeds directly into the main thesis.
2026 Looks Like a Bridge Year, Not a Breakout Year
If we have to give the next year a name, it is not a breakout year. It is also not a stabilization year. It is a cash bridge year. The company already made the aggressive move into Sde Dov, and it already added a more yielding layer through Rani Zim. Now it has to prove the system knows how to release cash back.
This is the bridge the board itself is leaning on:
| Potential source over the next two years | Amount presented in the filing | What has to happen for it to become real |
|---|---|---|
| Sale of remaining inventory in completed urban-renewal projects and MOMA | About NIS 120 million | The remaining units have to be sold at the prices the company assumes |
| Sale of land rights in Einstein 33A and 35 | About NIS 100 million | The rights sales need to close and the cash actually needs to come in, including part of the accelerated payment option |
| "Free" surpluses from Sommeil 124 and Jaffa Saharon | About NIS 600 million | Projects need to be completed, inventory sold, and surplus release allowed on the terms the company assumes |
That is exactly the difference between theoretical backlog and a balance-sheet read. All three lines carry conditions: sales pace, price, levies, buyer completion, execution timing, and in some cases restrictions on moving money upstream. That is why 2026 should be read as a test year, not as a comfort year.
What Would Improve the Read
The first thing that would improve the read is continued marketing and selling in FIRST without renewed deterioration in sales quality. The filing already proves the company can sell fast. Now it needs to show it is not buying that pace at too high a commercial price.
The second is real progress in Sde Dov from the layer of financed land and early marketing into the layer of permit, project accompaniment, and execution. If one of the external frictions there, parks, soil, or permit timing, is materially delayed, the delay will hit both timeline and financing cost.
The third is Shadal. A binding transaction there can change the tone quickly. Another exclusivity extension or another credit rollover without a signed deal would do the opposite.
What Would Weaken the Read
If the company has to return to more aggressive concessions closer to 2024 levels in order to keep sales pace, sales quality will weaken. If surpluses from Sommeil, Jaffa, and Einstein are delayed, the cash bridge will lengthen. And if Shadal stays open without either a transaction or a more stable funding path, the market will start reading it less as optional upside and more as an unresolved burden.
Risks
Strong Sales Do Not Eliminate Collection Risk
The company itself makes clear that in contracts with easier payment terms or index relief, it does not perform independent underwriting of apartment buyers. That means the risk does not need to fully materialize to matter. It is enough for the market to understand that part of the sales pace rests on more flexible commercial terms for the market to assign a lower quality factor to those sales.
Sde Dov Is Both an Execution Risk and a Time Risk
In FIRST, the risk is not only cost. It is also timing. Any delay in permits, execution, or the handling of the soil issue can lengthen the period in which the land sits on the balance sheet pulling financing cost before the project starts releasing real cash value.
Shadal Is a Financing Risk Disguised as Attractive Optionality
As long as Shadal does not turn into either a binding transaction or a more stable financing path, it stays on the line between a high-quality asset and a pocket of uncertainty. This is exactly the kind of asset the market likes in theory but struggles to fully credit while its end-state is still open.
Value Created Is Not Always Value Accessible
Rani Zim, Lodwipol, Shadal, the development book. Hagag has plenty of value. But in a company like this, the reader must constantly ask not only whether value is being created, but where it is being created, at what layer, and when it can actually travel up to common shareholders. That is one of the reasons the market can like the story and still stay cautious.
Short Read
Short-interest data does not tell a story of severe market distress here. On April 3, 2026 short float stood at 1.18%, with SIR at 2.7 days. That is somewhat above the sector average of 0.84% in short float, but nowhere near the zone where short positioning becomes a standalone thesis. Even the early-2026 peak, 1.62% short float and 6.82 days to cover, came down later.
The implication in one line: the market is cautious, but not aggressively positioned against the stock. The center of gravity remains fundamental, not technical.
Conclusions
Hagag exits 2025 as a company that has proved it has real selling power, strong positioning in high-value demand zones, and the ability to broaden the story through Rani Zim. But the filing also makes clear that the story is still not clean: it is leveraged, cash-heavy, and dependent on several transition points the market has not yet received as finished outcomes.
Current thesis in one line: Hagag is no longer being judged mainly on whether it knows how to sell, but on whether it can turn record sales into cash without making the balance sheet even heavier.
What changed versus the prior read? First, Sde Dov is no longer an idea. It is a major balance-sheet commitment. Second, Rani Zim adds real diversification. Third, sales quality improved versus 2024, but not to the point where the market should stop asking who is funding the pace. And fourth, Shadal moved from the world of optional upside into the world of "either close it, or keep carrying it."
The strongest counter-thesis is that the company has already done the hard move, bought the Sde Dov land, sold quickly, opened a more yielding diversification layer, and kept covenants comfortably intact. Under that reading, 2025 is a one-off heavy investment year from which the bridge is already being built. That is a legitimate argument. The problem is that it still depends on too many "ifs": if Sde Dov progresses without delay, if surpluses really get released, and if Shadal closes.
What can change the market's read over the short to medium term? A binding transaction in Shadal, more sales in FIRST without weaker commercial quality, clear permit and accompaniment progress in Sde Dov, and proof that the NIS 120 million, NIS 100 million, and NIS 600 million bridge assumptions are actually starting to show up. On the other hand, another delay in one of those nodes would remind the market that the story is attractive, but still running on financing.
Why does this matter? Because in a leveraged development company, value is not measured only by future gross profit. It is also measured by time, accessibility, and the financing cost required to reach it.
| Metric | Score | Explanation |
|---|---|---|
| Overall moat strength | 3.5 / 5 | Strong planning, branding, and selling edge in Tel Aviv, but not a moat that disconnects the company from rates and financing conditions |
| Overall risk level | 4.0 / 5 | The main risk sits in cash timing, Sde Dov execution, and the gap between accounting value and accessible value |
| Value-chain resilience | Medium | The company still relies on open credit markets, permits, contractors, and buyers who need to complete payments |
| Strategic clarity | Medium to high | The direction is clear, Tel Aviv development, diversification through Rani Zim, but execution still has to prove it can self-fund |
| Short positioning | 1.18% short float, 2.7 days to cover | Caution exists, but short interest is not unusually contradicting fundamentals |
The next 2 to 4 quarters present a very clear hurdle. For the thesis to strengthen, the company needs to show that sales turn into surpluses, that Sde Dov progresses without unusual regulatory or cost friction, and that Shadal stops being a project waiting for a transaction. If one of these weakens, both the equity and the bonds will be read again through the same old question: how much of Hagag's value is already accessible, and how much of it is still only promising.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.
Hagag's 2025 sales record was real, but not clean: the company almost fully exited developer loans, yet still relied heavily on 20/80 structures, linear-payment schedules, index relief, and a FIRST sales engine that was still absorbing planning changes.
Shadal is a high-quality asset that has already moved close to permit stage, but until there is either a binding transaction or a stable accompaniment framework it remains primarily a financing bottleneck with value that is more visible on paper than in cash.